Up to 60% of congenital and early-onset hearing loss is caused by genetic mutations in an inherited gene, and gene therapy has recently emerged as a potential treatment option. To provide a standardized framework for conducting safe, high-quality clinical trials, a group of international experts has put together guidelines on the administration of gene therapy for hereditary hearing loss.
This article was originally published on MedicalXpress.com

